Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma.

Kylie FletcherSaba RehmanRebecca IrlmeierFei YeDouglas B Johnson

Published in: The oncologist (2024)

Late immunotherapy infusion times were associated with inferior outcomes when considering all infusions, but not when considering initial (first 4) infusions.

Keyphrases

low dose
type diabetes
skeletal muscle
weight loss